肾动脉栓塞治疗医源性肾血管损伤:5年经验
术前血红蛋白水平较低者手术时间较长(p=0.016),术后1周血肌酐较术前显著降低(p=0.04)。
要点
- 术后1周血肌酐较术前显著降低(p=0.04),术后即刻与术前无显著差异(p=0.23)。
- 术前血红蛋白较低者手术时间较长(p=0.016),肾周血肿范围与损伤原因相关(p=0.028)。
核心结论
- 肾动脉栓塞治疗医源性肾血管损伤安全有效,技术成功率和临床成功率高、并发症率低。
研究设计与样本
- 回顾性分析2013年1月至2017年12月在Fondazione Policlinico Universitario「A. Gemelli」IRCCS行肾动脉栓塞的全部操作。
- 共纳入28例患者的28次肾动脉栓塞操作,其中男性21例、女性7例。
关键影像表现/征象
- 19/28例为假性动脉瘤,7/28例为活动性出血,1/28例为动静脉瘘,4/28例同时存在两种医源性肾血管损伤。
- 肾周血肿范围与医源性肾血管损伤原因具有相关性(p=0.028)。
临床应用与阅片要点
- 术后1周血肌酐较术前显著降低(p=0.04),术前与术后即刻平均血肌酐无显著差异(p=0.23)。
- 术前血红蛋白较低者手术时间较长(p=0.016)。
- 单独使用胶或胶联合其他材料与弹簧圈同样安全。
- 28例中3例需再次治疗,2/28例(7.1%)出现轻微并发症,无严重并发症。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Evaluate the efficacy and safety of renal artery embolization (RAE) for iatrogenic renal vascular injuries (IRVI) management at Fondazione Policlinico Universitario "A. Gemelli" IRCCS, in the last 5 years.
METHODS: Retrospective analysis of all RAE procedures performed from January 2013 to December 2017. Patients-related (age, sex, vascular variants, hemoglobin and serum creatinine), IRVI-related (type and vascular level of IRVI, presence and extension of hematoma), management-related (temporal interval between diagnostic imaging and RAE) and procedure-related (embolic materials, technical success, clinical success and complications) parameters were evaluated.
RESULTS: 28 RAE procedures performed on 28 patients (21 males; 7 females) were included. 19/28 patients had pseudoaneurysm, 7/28 active bleeding and 1/28 arteriovenous fistula; 4/28 patients had a combination of 2 IRVI.The extent of perirenal hematoma showed correlation with the cause of IRVI (p = 0.028).Technical success was achieved in all patients whereas clinical success in 25/28 (89.3%), with 3 patients requiring re-treatment. Minor complications were observed during 2/28 (7.1%) endovascular procedures. No major complications occurred. A longer procedural time was observed in patients with lower pre-procedural levels of hemoglobin (p = 0.016).No differences were found in mean serum creatinine (p = 0.23) before and immediately after treatment, while values of creatinine at 1 week from the procedure were significantly lower (p = 0.04).
CONCLUSION: RAE is safe and effective for the management of iatrogenic IRVI showing high technical and clinical success rate and low complication rate.
ADVANCES IN KNOWLEDGE: Low pre-procedural hemoglobin levels increase procedural duration time. Glue alone or in combination with other materials is as safe as coils.
引用
- Contegiacomo A, Amodeo EM, Cina A, et al. Renal artery embolization for iatrogenic renal vascular injuries management: 5 years' experience. Br J Radiol. 2019. PMID: 31794248. doi:10.1259/bjr.20190256
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。